Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MOMETASONE Cause Brain natriuretic peptide increased? 88 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Brain natriuretic peptide increased have been filed in association with MOMETASONE (MOMETASONE FUROATE). This represents 5.2% of all adverse event reports for MOMETASONE.

88
Reports of Brain natriuretic peptide increased with MOMETASONE
5.2%
of all MOMETASONE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Brain natriuretic peptide increased From MOMETASONE?

Of the 88 reports.

Is Brain natriuretic peptide increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MOMETASONE. However, 88 reports have been filed with the FAERS database.

What Other Side Effects Does MOMETASONE Cause?

Asthma (522) Dyspnoea (497) Wheezing (459) Gastrooesophageal reflux disease (406) Therapeutic product effect incomplete (400) Drug ineffective (318) Sleep disorder due to a general medical condition (318) Cardiac disorder (311) Headache (308) Loss of personal independence in daily activities (301)

What Other Drugs Cause Brain natriuretic peptide increased?

SACUBITRIL\VALSARTAN (252) MACITENTAN (192) TADALAFIL (176) ASPIRIN (157) SELEXIPAG (156) RIVAROXABAN (134) ROSUVASTATIN (133) TAMSULOSIN (131) CLOPIDOGREL BISULFATE (127) TREPROSTINIL (124)

Which MOMETASONE Alternatives Have Lower Brain natriuretic peptide increased Risk?

MOMETASONE vs MOMETASONE FUROATE MOMETASONE vs MOMETASONE FUROATE\OLOPATADINE MOMETASONE vs MONOMETHYL MOMETASONE vs MONTELUKAST MOMETASONE vs MONTELUKAST\MONTELUKAST

Related Pages

MOMETASONE Full Profile All Brain natriuretic peptide increased Reports All Drugs Causing Brain natriuretic peptide increased MOMETASONE Demographics